SecBot SecBot
6-K ·Filed Nov 5, 2026

QGEN

QIAGEN N.V.
BEARISH
Impact 6/10
Horizonweeks Processed11d 7h ago SEC0001015820-26-000063
6-K: Earnings release
Actionable Insight ▼ Bearish

The EPS miss and declining net income are negative for the standalone stock, but the announced EQT takeover at a premium likely overhangs the price. Monitor regulatory approvals and shareholder vote for the takeover, expected to close mid-2027. The earnings miss may reduce the likelihood of a competing bid.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$50.33
T+0 close · Nov 5, 2026 · via day close
Latest settled
−0.87%
T+5 · $49.89 · next T+20 in 20d
Vs SPY
−3.47%
α at T+5
Latest observation
−0.92%
T+6 · FF3 residual α
  1. T+0 · Nov 6 $50.33entry
  2. T+1 · 8d ago +0.44%α −1.93% · $50.55
  3. T+5 · 4d ago −0.87%α −3.47% · $49.89
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

QIAGEN reported Q3 2026 net sales of $547.9M (+3% YoY) and GAAP diluted EPS of $0.51, below the consensus estimate of $0.63. Net income declined to $105.7M from $130.0M a year ago, pressured by higher restructuring costs and a normalized tax rate. The filing also discloses a subsequent event: a public takeover offer by EQT Private Equity at EUR 46.50 per share, valuing the company at approximately EUR 10.8 billion enterprise value.

Key Financial Metrics

EPS
$0.51
est $0.63 · -19.1%
Revenue
$547.9M
est $538.1M · +1.8% · +2.9% YoY
Rating
miss
Gross Margin
64.6%

Key Facts

  • Q3 2026 net sales $547.9M, up 3% YoY from $532.6M
  • GAAP diluted EPS $0.51, down from $0.60 YoY; consensus was $0.63
  • Net income $105.7M vs $130.0M in Q3 2025, a 19% decline
  • Gross margin improved to 64.6% from 62.2% YoY, benefiting from Parse acquisition and tariff refunds
  • Operating income margin stable at 24.2% vs 24.3% YoY
  • Restructuring, acquisition, integration and other costs surged to $19.2M from $8.1M YoY
  • Effective tax rate normalized to 20.1% from 3.5% in Q3 2025 (which benefited from a worthless stock deduction)
  • On October 21, 2026, QIAGEN announced a public takeover offer by EQT Private Equity at EUR 46.50 per share, valuing the company at approximately EUR 10.8 billion enterprise value
  • Sample technologies grew 10% YoY; PCR/nucleic acid amplification declined 5%; Genomics/NGS grew 8%
  • Cash and cash equivalents $805.1M, down from $839.0M at year-end 2025

Financial Impact

EPS miss of $0.12 vs consensus ($0.51 actual vs $0.63 estimate), net income down 19% YoY; restructuring charges $19.2M in Q3

epsnet incomerestructuring costs

Segment Breakdown

SegmentRevenueGrowth
Sample technologies$187.4M+10.2%
Diagnostic solutions$209.4M+0.4%
PCR/Nucleic acid amplification$71.2M-5.4%
Genomics/NGS$66.0M+8.5%
Other$13.8M-21.9%

Risk Factors

  • Takeover may not complete due to regulatory hurdles or insufficient shareholder acceptance
  • If deal fails, stock could re-rate lower given the earnings miss and elevated restructuring costs
  • Patent litigation from Parse acquisition could result in additional damages up to $9.8M
  • Restructuring costs expected to continue through 2026, pressuring margins

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001015820-26-000063
Document: a2026q3form6-k.htm0001015820-26-000063
Document: 0001015820-26-000063-index-headers.html0001015820-26-000063
Document: 0001015820-26-000063-index.html0001015820-26-000063
Document: 0001015820-26-000063.txt0001015820-26-000063
Earnings Context (Synthetic; results releases only)0001015820-26-000063

Track record

7 reports on QGEN

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +0.99% at T+5 after the Oct 27, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $50.33 to $49.89 Now $49.81 −1.03% ▼ −0.87% −3.47% vs SPY
  2. Nov 5, 202611d ago 6-K Bearish 6/10 Viewing Entry $50.33 to $49.89 Now $49.81 +1.03% ▲ +0.87% +3.47% vs SPY
  3. Nov 5, 202611d ago 6-K Neutral 5/10 No price data
  4. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $50.86 to $50.10 Now $49.81 −2.06% ▼ −1.49% −4.78% vs SPY
  5. Oct 27, 202620d ago SC TO-C Bullish 7/10 Entry $50.33 to $50.83 Now $49.81 −1.03% ▲ +0.99% +1.71% vs SPY
  6. Oct 23, 202624d ago 6-K Bullish 8/10 Entry $50.39 to $50.22 Now $49.81 −1.15% ▼ −0.34% +0.22% vs SPY
  7. Oct 22, 202625d ago SC TO-C Bullish 8/10 Entry $50.22 to $50.34 Now $49.81 −0.82% ▲ +0.24% −0.47% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 8h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026